Items | TARP group | OF group | P |
---|---|---|---|
ADI/mm | |||
 Before operation | 6.3 ± 2.3 | 5.7 ± 1.9 | .31 |
 At discharge | 1.9 ± 1.1 | 2.9 ± 1.2 | <.01 |
 3-month follow-up | 1.9 ± 1.1 | 2.9 ± 1.2 | <.01 |
CL/mm | |||
 Before operation | 11.1 ± 3.5 | 10.2 ± 4.8 | .43 |
 At discharge | 1.0 ± 1.8 | 3.0 ± 3.1 | < .01 |
 3-month follow-up | 1.0 ± 1.8 | 3.0 ± 3.1 | < .01 |
CCA/° | |||
 Before operation | 122.1 ± 14.7 | 123.1 ± 18.0 | .82 |
 At discharge | 151.5 ± 10.2 | 139.5 ± 17.2 | < .01 |
 3-month follow-up | 151.8 ± 10.1 | 139.6 ± 17.2 | < .01 |
CMA/° | |||
 Before operation | 125.4 ± 10.9 | 130.1 ± 16.4 | .20 |
 At discharge | 156.4 ± 7.1 | 145.0 ± 14.2 | <.01 |
 3-month follow-up | 157.0 ± 6.9 | 145.3 ± 14.3 | <.01 |
JOA score | |||
 Before operation | 10.7 ± 1.5 | 11.1 ± 1.3 | .34 |
 At discharge | 12.6 ± 1.3 | 12.0 ± 1.0 | .06 |
 3-month follow-up | 13.8 ± 1.0 | 13.0 ± 0.9 | <.01 |
 6-month follow-up | 14.3 ± 0.8 | 13.7 ± 0.6 | <.01 |
 12-month follow-up | 15.4 ± 1.00 | 14.5 ± 0.9 | <.01 |
Bone fusion/n (%) | |||
 3-month follow-up | 22 (62.9%) | 7 (33.3%) | .03 |
 6-month follow-up | 30 (85.7%) | 13 (61.9%) | .04 |
 12-month follow-up | 35 (100%) | 20 (95.2%) | .36 |
 Final follow-up | 35 (100%) | 21 (100%) | NS |